Detection of Active BoNT/C and D by EndoPep-MS Using MALDI Biotyper Instrument and Comparison with the Mouse Test Bioassay

Detection of Active BoNT/C and D by EndoPep-MS Using MALDI Biotyper Instrument and Comparison with the Mouse Test Bioassay

Botulinum neurotoxins (BoNTs) are among the most poisonous known biological substances, and therefore the availability of reliable, easy-to use tools for BoNT detection are important goals for food safety and human and animal health. The reference method for toxin detection and identification is the...

Full description

Bibliographic Details
Main Authors:	Ilenia Drigo, Elena Tonon, Simone Pascoletti, Fabrizio Anniballi, Suzanne R. Kalb, Luca Bano
Format:	Article
Language:	English
Published:	MDPI AG 2021-12-01
Series:	Toxins
Subjects:	<i>Clostridium botulinum</i> BoNT/C BoNT/D BoNT/CD BoNT/DC MALDI Biotyper
Online Access:	https://www.mdpi.com/2072-6651/13/1/10

Similar Items

Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of Botulism
by: Robert P. Webb, et al.
Published: (2017-09-01)

Crystal Structure of the Receptor-Binding Domain of Botulinum Neurotoxin Type HA, Also Known as Type FA or H
by: Guorui Yao, et al.
Published: (2017-03-01)

New 9-aminoacridine derivatives as inhibitors of Botulinum neurotoxins and P. falciparum malaria
by: Tot Mikloš, et al.
Published: (2013-01-01)

Variability of Botulinum Toxins: Challenges and Opportunities for the Future
by: Christine Rasetti-Escargueil, et al.
Published: (2018-09-01)

Antibodies and Vaccines against Botulinum Toxins: Available Measures and Novel Approaches
by: Christine Rasetti-Escargueil, et al.
Published: (2019-09-01)

Sheep Monoclonal Antibodies Prevent Systemic Effects of Botulinum Neurotoxin A1
by: Charles B. Shoemaker, et al.
Published: (2012-12-01)

Towards New Uses of Botulinum Toxin as a Novel Therapeutic Tool
by: Karen Perrow, et al.
Published: (2011-01-01)

Humoral Response of Buffaloes to a Recombinant Vaccine against Botulism Serotypes C and D
by: Denis Y. Otaka, et al.
Published: (2017-09-01)

The 25 kDa H<sub>CN</sub> Domain of Clostridial Neurotoxins Is Indispensable for Their Neurotoxicity
by: Julian Deppe, et al.
Published: (2020-11-01)

Engineering of Botulinum Neurotoxins for Biomedical Applications
by: Robert P. Webb
Published: (2018-06-01)

Usos prácticos de la toxina botulínica en niños y adolescentes en medicina física y rehabilitación
by: S. Susana lillo, DRA., et al.
Published: (2014-03-01)

Qualitative and Quantitative Detection of Botulinum Neurotoxins from Complex Matrices: Results of the First International Proficiency Test
by: Sylvia Worbs, et al.
Published: (2015-11-01)

Cell-Based Reporter Release Assay to Determine the Potency of Proteolytic Bacterial Neurotoxins
by: Andrea Pathe-Neuschäfer-Rube, et al.
Published: (2018-09-01)

Clostridium botulinum Type B Isolated From a Wound Botulism Case Due to Injection Drug Use Resembles Other Local Strains Originating From Hawaii
by: Jessica L. Halpin, et al.
Published: (2021-07-01)

SiMa Cells for a Serotype Specific and Sensitive Cell-Based Neutralization Test for Botulinum Toxin A and E
by: Nicola Bak, et al.
Published: (2017-07-01)

Botulinum Toxin for Neuropathic Pain: A Review of the Literature
by: Hyun-Mi Oh, et al.
Published: (2015-08-01)

Analgesic potential of different available commercial brands of botulinum neurotoxin-A in formalin-induced orofacial pain in mice
by: Thays Crosara Abrahão Cunha, et al.
Published: (2021-11-01)

Comparison of the Expression Changes after Botulinum Toxin Type A and Minocycline Administration in Lipopolysaccharide-Stimulated Rat Microglial and Astroglial Cultures
by: Joanna Mika, et al.
Published: (2017-04-01)

Type C waterborne botulism outbreaks in buffaloes (Bubalus bubalis) in the Amazon region
by: Felipe M. Salvarani, et al.

Immunogenicity of a Bivalent Non-Purified Recombinant Vaccine against Botulism in Cattle
by: Clóvis Moreira, et al.
Published: (2018-09-01)

The destructive effect of botulinum neurotoxins on the SNARE protein: SNAP-25 and synaptic membrane fusion
by: Bin Lu
Published: (2015-06-01)

The safety and efficacy of botulinum toxin A on the treatment of depression
by: Qilin Zhang, et al.
Published: (2021-09-01)

Structural and Biochemical Characterization of Botulinum Neurotoxin Subtype B2 Binding to Its Receptors
by: Jonathan R. Davies, et al.
Published: (2020-09-01)

Development and Characterization of Monoclonal Antibodies to Botulinum Neurotoxin Type E
by: Candace S. Bever, et al.
Published: (2019-07-01)

High yield derivation of enriched glutamatergic neurons from suspension-cultured mouse ESCs for neurotoxicology research
by: Hubbard Kyle S, et al.
Published: (2012-10-01)

Combined Effects of Isokinetic Training and Botulinum Toxin Type A on Spastic Equinus Foot in Patients with Chronic Stroke: A Pilot, Single-blind, Randomized Controlled Trial
by: Nicoletta Cinone, et al.
Published: (2019-04-01)

Clostridia in Insect Processed Animal Proteins—Is an Epidemiological Problem Possible?
by: Tomasz Grenda, et al.
Published: (2021-03-01)

Mechanism of Ganglioside Receptor Recognition by Botulinum Neurotoxin Serotype E
by: Geoffrey Masuyer, et al.
Published: (2021-08-01)

Current Status and Future Directions of Botulinum Neurotoxins for Targeting Pain Processing
by: Sabine Pellett, et al.
Published: (2015-11-01)

AbobotulinumtoxinA (Dysport<sup>®</sup>), OnabotulinumtoxinA (Botox<sup>®</sup>), and IncobotulinumtoxinA (Xeomin<sup>®</sup>) Neurotoxin Content and Potential Implications for Duration of Response in Patients
by: Malgorzata Field, et al.
Published: (2018-12-01)

Botulinum Toxin Type A—A Modulator of Spinal Neuron–Glia Interactions under Neuropathic Pain Conditions
by: Ewelina Rojewska, et al.
Published: (2018-04-01)

Considerations on patient-related outcomes with the use of botulinum toxins: is switching products safe?
by: Fraint A, et al.
Published: (2016-02-01)

Best Clinical Practice in Botulinum Toxin Treatment for Children with Cerebral Palsy
by: Walter Strobl, et al.
Published: (2015-05-01)

Association of Long-Term Treatment by Botulinum Neurotoxins and Occupational Therapy with Subjective Physical Status in Patients with Post-Stroke Hemiplegia
by: Toyohiro Hamaguchi, et al.
Published: (2019-08-01)

Rapid Microfluidic Assay for the Detection of Botulinum Neurotoxin in Animal Sera
by: Lmar Babrak, et al.
Published: (2016-01-01)

Emerging Opportunities in Human Pluripotent Stem-Cells Based Assays to Explore the Diversity of Botulinum Neurotoxins as Future Therapeutics
by: Juliette Duchesne de Lamotte, et al.
Published: (2021-07-01)

Effect of early use of AbobotulinumtoxinA after stroke on spasticity progression: Protocol for a randomised controlled pilot study in adult subjects with moderate to severe upper limb spasticity (ONTIME pilot)
by: Keng He Kong, et al.
Published: (2017-06-01)

A Pilot Study of Two Different Constraint-Induced Movement Therapy Interventions in Children With Hemiplegic Cerebral Palsy After Botulinum Toxin Injection During Preschool Education
by: Chin-Lung Wu, et al.
Published: (2020-10-01)

Real-Time Monitoring of a Botulinum Neurotoxin Using All-Carbon Nanotube-Based Field-Effect Transistor Devices
by: Nam Hee Lee, et al.
Published: (2018-12-01)

Detection of Botulinum Neurotoxin Serotypes C and D, and Their Effects on Expressions of SNAP-25 and Synaptobrevin in Ruminants: An Immunohistochemical Study
by: Mehmet Burak ATEŞ, et al.
Published: (2021-03-01)

Cannot write session to /tmp/vufind_sessions/sess_rdnki1hoojph11lu6giua1bpii